CAMBRIDGE, England--(BUSINESS WIRE)--Sphere Fluidics, a leading provider of innovative picodroplet-based microfluidics solutions for functional single cell analysis and isolation, today announced the ...

CAMBRIDGE, England--(BUSINESS WIRE)--Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, announced ...

Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect® Fc Fusion, a novel assay designed to ...

Sphere Fluidics, a leading provider of innovative droplet-based microfluidics solutions for single-cell analysis and isolation, today shared details of Cyto-Mine® Chroma, the second generation of its ...

Sphere Fluidics has launched the Cyto-Mine ® Chroma to accelerate and streamline workflows. Cyto-Mine Chroma builds on the original Cyto-Mine platform’s ability to leverage picodroplet technology to ...

Sphere Fluidics announced the launch of Cyto-Cellect ® PLUS, a fluorescence resonance energy transfer (FRET) assay to enable researchers to quantify IgG productivity with high sensitivity. The new ...

Article ‘Count’ and ‘Share’ for Sphere Fluidics Limited based on listed parameters only. The articles listed below published by authors from Sphere Fluidics Limited, organized by journal and article, ...

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Averto, Bracco, Eyenovia, Lucid, Natera, Sphere Fluidics, Zereau.